Acouspin's patented technology offers a low entry cost for initiating nanofiber production. It enables the creation of customisable nanofibers that can be adapted in real-time during the production process. It ensures consistent output levels and is designed to be user-friendly. Acouspin nanofibers are up to 100 times smaller than a human hair. They can be used to filter bacteria from the air or microplastics from water.
Innovative technology for diverse applications
Acouspin is pioneering a cutting-edge technology known as Ultrasound Enhanced Electrospinning (USES). This novel method allows to produce nanometer-scale fibers from a variety of materials, marking a significant advancement in the field of electrospinning. The flexibility of Acouspin technology opens a wide range of applications across various industries, including filtration, e-mobility batteries, wound care, and pharmaceuticals.
“This is a great example of what can be accomplished by integrating different scientific disciplines—AI, physics, and materials science—to create transformative deep-tech solutions,” says Professor of electronics and industrial physics at the University of Helsinki, Ari Salmi.
Scalable production for industrial use
The company has successfully demonstrated the scalability of its production technology and is now focused on harnessing the commercial potential of nanofiber manufacturing across multiple sectors. With increasing demand for nanofibers, Acouspin is well-positioned to transition from small-scale production to full industrial capabilities. Ultrasound technology with a great industrial scalability has the potential to enter a market worth 20 billion.
"We are selling our technology with a small set-up fee and pay-as-you-go basis, this lowers the entry barrier to uptake Acouspin's technology. The service includes an intuitive user interface and an AI-driven processing to continuously improve production output on the fly," says CEO Maximilian LeRoux, and continues:
“We are bringing nanofiber production from Expert-Only Processes to an AI-Driven Nanofiber Tool. By removing barriers to entry and optimising production efficiency, we are paving the way for broader adoption of nanofibers in everyday applications.”
Research collaboration and expertise leading to a spinout company
Acouspin's technology is rooted in over a decade of pioneering scientific research conducted at the University of Helsinki, in collaboration with Tartu University in Estonia. The research team, led by Professor Ari Salmi from the Department of Physics Division of Materials Science Electronics Research Laboratory (ETLA), laid the groundwork for this innovative spinout.
"The commercialisation journey of Acouspin, starting from a wound care concept and developing into a cutting-edge nanofiber technology demonstrates the power of collaboration. With its strong industrial commercial potential, we are eager to see Acouspin succeeding," says CEO, Helsinki Innovation Services Ltd, Marko Hakovirta.
Co-founded by CEO Maximilian LeRoux, CTO Felix Sundblad, and Lead Engineer Jere Hyvönen, Acouspin received seed funding from Helsinki University Funds. Technology transfer and commercialisation company of the University of Helsinki, Helsinki Innovation Services Ltd provided support for the preparation of commercialisation. Acouspin was established in 2024, and it operates from Espoo, Finland.
For further information:
Acouspin, CEO, Maximilian LeRoux, media@acouspin.com